Cargando…
Non-sentinel lymph node metastases risk factors in patients with breast cancer with one or two sentinel lymph node macro-metastases
Approximately 59 % of patients with breast cancer with one or two sentinel lymph nodes (1–2 SLN) macrometastases do not benefit from axillary lymph node dissection (ALND), which may also incur morbidities. It is necessary to evaluate the association between various clinicopathological characteristic...
Autores principales: | Xu, Liu-yan, Zhao, Jing, Wang, Xuan, Jin, Xin-yan, Wang, Bei-bei, Fan, Ying-yi, Pei, Xiao-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641163/ https://www.ncbi.nlm.nih.gov/pubmed/37964832 http://dx.doi.org/10.1016/j.heliyon.2023.e21254 |
Ejemplares similares
-
Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases
por: Zheng, Jianwei, et al.
Publicado: (2018) -
A nomogram for intraoperatively predicting non-sentinel lymph node metastases in early breast cancer patients with positive sentinel lymph nodes
por: Wang, Yu, et al.
Publicado: (2023) -
Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes
por: Den Toom, Inne J., et al.
Publicado: (2016) -
Prediction of Non-Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Metastases: Evaluation of the Tenon Score
por: Andersson, Y, et al.
Publicado: (2012) -
Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
por: Lee, Jina, et al.
Publicado: (2018)